BioSpace News Archive

SINOMED, a developer of innovative neuro- and cardiovascular technologies, announced the completion of the 1-year follow-up in the PIONEER-III, randomized global trial evaluating the BuMA Supreme Drug-Eluting Coronary Stent.

CLINUVEL PHARMACEUTICALS revealed PRÉNUMBRA®, the Company’s second afamelanotide product in development.

Vela Diagnostics announced that an automated version of its COVID-19 detection test, the ViroKey™ SARS-CoV-2 RT-PCR Test v2.0, has received the CE mark for in vitro diagnostic use as well as Provisional Authorisation from the Health Sciences Authority in Singapore.

The global medical gas equipment market is prognosticated to be significantly advantaged by the augmenting prevalence of respiratory ailments strengthening the rise of point-of-care diagnostics.

The global TNF inhibitors market was valued around US$ 40,369.8 Mn in 2017.

As per the latest research study by TMR, the membrane microfiltration market is anticipated to witness an impressive growth at a CAGR of over 7.5% through 2028.

--Denise Adams will lead multidisciplinary team caring for children with complex vascular anomalies, identifying causes and treatments for these rare conditions--

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral DNA–based cancer immunotherapies, today announced the promising potential of its novel DNA–encodable vaccine candidate, CORVax12, which is designed to act as a prophylactic vaccine to prevent COVID-19

NovaSight , the Israeli start-up specializing in ground-breaking vision care solutions based on AI and eye tracking technology announced today that it has finalized its round A financing totaling $8M . The round was led by Rimonci Capital and joined by world leading strategic investors from both pharmaceutical and medical dev

Industry leader at forefront of initiative to evaluate methods and establish guidelines to enhance employee performance as organizations navigate their return to offices. ROCHESTER, Minn.--( BUSINESS WIRE )-- The Well Living Lab, a Delos and Mayo Clinic collaboration dedicated to researching the indoor environment’s impact on human health, today announced that Empire State Realty Trust, Inc., a real estate leader, will join the Well Living Lab Allian